Doxepin (hydrochloride)
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 1mL(10 mM in DMSO) | ¥454.00 | 现货 | |
| 5g | ¥1110.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
Doxepin, a tricyclic antidepressant, is a potent histamine H1 antagonist [1]. The histamine receptors belong to a family of G protein–coupled receptors activated by their primary endogenous ligand histamine. The H1 receptor has been expressed in smooth muscles, vascular endothelial cells, heart, and the central nervous system [2].
In vitro: Doxepin was a moderately potent competitive inhibitor of serotonin uptake in human blood platelets in vitro, with an inhibitory constant Ki of ~0.2 μM. Doxepin (100 μM) rapidly increased the efflux of serotonin from platelets [1].
In vivo: In rats and dog, oral administration of doxepin was well absorbed and quickly appeared in the blood. Numerous metabolites of doxepin were observed in liver and in urine, only doxepin and demethyl doxepin were found in the rat brain[3]..
Clinical trials: Doxepin has been marketed under many brand names worldwide. The oral topical formulations of doxepin are FDA-approved for the treatment of patients with major depressive disorder, primary insomnia, chronic urticaria, and anxiety [4,5,6].
References:
[1] Lingjrde O. Effect of doxepin on uptake and efflux of serotonin in human blood patelets in vitro[J]. Psychopharmacology, 1976, 47(2): 183-186.
[2] Hill S J, Ganellin C R, Timmerman H, et al. International Union of Pharmacology. XIII. Classification of histamine receptors[J]. Pharmacological reviews, 1997, 49(3): 253-278.
[3] Hobbs D C. Distribution and metabolism of doxepin[J]. Biochemical pharmacology, 1969, 18(8): 1941-1954.
[4] Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study[J]. Journal of Clinical Psychiatry, 2001, 62(6): 453-463.
[5] Feighner J P, Cohn J B. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder[J]. The Journal of clinical psychiatry, 1985, 46(3 Pt 2): 20-25.
[6] Goldsobel A B, Rohr A S, Siegel S C, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria[J]. Journal of allergy and clinical immunology, 1986, 78(5): 867-873.
产品性质
| 物理外观 | Solid |
| CAS号 | 1229-29-4 |
| 分子式 | C19H21NO·HCl |
| 分子量 | 315.8 |
| 小分子别名 | Doxepin Hydrochloride |
| 化学名称 | 3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-1-propanamine, monohydrochloride |
| 溶解度 | ≥15.85 mg/mL in DMSO; ≥23.7 mg/mL in H2O; ≥26.5 mg/mL in EtOH |
| SMILES | CN(C)CC/C=C1\c(cccc2)c2OCc2c\1cccc2.Cl |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | 盐酸多塞平是一种口服活性三环类抗抑郁药。盐酸多塞平是一种强效的选择性组胺受体 H1 拮抗剂。盐酸多塞平也是一种强效的 CYP450 抑制剂,能显著抑制 CYP450 2C19 和 1A2。作为一种三环类抗抑郁药,多塞平可抑制血清素和去甲肾上腺素的再摄取。多塞平对特应性皮炎、慢性荨麻疹有治疗作用,能改善认知过程, 保护中枢神经系统。多塞平还被认为是一种抗氧化保护因子。 |



沪公网安备 31011002003500